On February 23, 2026, Navan Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased Navan common stock pursuant to and/or traceable to the Company’s Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s October 2025 IPO.

On February 23, 2026, Navan Inc.  was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Lakeland securities between December 1, 2023 and December 9, 2025, both dates inclusive (the "Class Period").

On February 20, 2026, officers and directors of Zynex, Inc. were sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who persons and entities that purchased or otherwise acquired Zynex securities between February 25, 2021 to December 15, 2025, inclusive (the “Class Period”).

On February 20, 2026, Corcept Therapeutics Incorporated was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Corcept common stock between October 31, 2024, and December 30, 2025, inclusive (the “Class Period”).

On February 18, 2026, NuScale Power Corporation was sued for violations of the federal securities laws in the United States District Court for the District of Oregon on behalf of all purchasers of NuScale Class A common stock between May 13, 2025 and November 6, 2025, both dates inclusive (the “Class Period”).

On February 17, 2026, PayPal Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired PayPal common stock between February 25, 2025, to February 2, 2026, inclusive (the “Class Period”).

On February 17, 2026, Enphase Energy, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Enphase securities between April 22, 2025 and October 28, 2025 both dates inclusive (the “Class Period”).

On February 16, 2026, Nabors Energy Transition Corp. II was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of all holders of Nabors Energy Transition Corp. II (the “SPAC”) Class A common stock (the “Public Shares”) as of the SPAC's redemption on December 3, 2025.

On February 16, 2026, Ostin Technology Group Co., Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who all investors who
purchased or otherwise acquired OST ordinary shares on the Nasdaq Stock Market (the "Nasdaq") between May 11, 2025, and June 26, 2025, inclusive (the "Class Period").

On February 13, 2026, REGENXBIO Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Maryland on behalf of investors who purchased or otherwise acquired REGENXBIO securities between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”).

On February 11, 2026, Kyndryl Holdings Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased or otherwise acquired publicly traded Kyndryl securities between August 7, 2024 and February 9, 2026, inclusive (the “Class Period”).

On February 10, 2026, uniQure N.V. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired uniQure ordinary shares between September 24, 2025, and October 31, 2025, inclusive (the “Class Period”).

On February 6, 2026, Masonite International Corporation was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of all sellers of the common stock of
Masonite between June 5, 2023 and February 8, 2024, inclusive (the “Class Period”).

On February 6, 2026, Inovio Pharmaceuticals, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased or otherwise acquired Inovio securities between October 10, 2023 and December 26, 2025, both dates inclusive (the “Class Period”).

On February 5, 2026, Pomdoctor, Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired PomDoctor securities between October 9, 2025 and December 11, 2025, inclusive (the “Class Period”).

On February 4, 2026, Ultragenyx Pharmaceutical Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Ultragenyx common stock between August 3, 2023, to December 26, 2025, inclusive (the “Class Period”).

On February 4, 2026, Mereo BioPharma Group Plc was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Mereo American Depositary Shares (“ADS”) between June 5, 2023, and December 26, 2025, inclusive (the “Class Period”).

On February 3, 2026, BlackRock TCP Capital Corp. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired BlackRock TCP securities between November 6, 2024 and January 23, 2026, inclusive (the “Class Period”).

On February 4, 2026, Oracle Corporation was sued for violations of the federal securities laws in the United States District Court for the District of Delaware on behalf of investors who purchased or acquired Oracle common stock betweenJune 12, 2025, and December 16, 2025, inclusive (the “Class Period”).

On February 2, 2026, Picard Medical Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Picard securities between September 2, 2025, and October 31, 2025, inclusive (the “Class Period”).